Analiza, Inc.

Cleveland, OH 44114

SBIR Award Summary

Total Number of Awards 10
Total Value of Awards $1.2MM
First Award Date 04/01/97
Most Recent Award Date 04/01/04

Key Personnel

Last Name Name Awards Contact
Zaslavsky Boris Y Zaslavsky 10

10 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/04 - 03/31/05

DESCRIPTION (provided by applicant): Higher-order structural information for biomolecules is an important component of quality control activities for recombinant proteins. Unfortunately, detailed structural information typically require highly complex, time-consuming experimental techniques (e.g., NMR or X-ray crystallography) that can not be co...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/02 - 08/31/03

We propose to develop a new methodology for measurement of hydrophobic properties of therapeutic agents. This information is important for Quantitative Structure-Activity Relationships (QSAR) analyses. While the QSAR analysis is widely used for common drugs, it is virtually non-existent for various technical reasons for biological agents. The ne...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-AI-02-05
Budget: 08/15/02 - 08/14/03

DESCRIPTION (Provided by applicant): Due to the anticipated significant increase in the number of potential vaccines for CDC Category A agents in the near future, it is imperative that a rapid response quality control technology be developed and validated. The key objective of this proposal is to develop and validate such a technology applicable...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/01 - 08/31/02

We propose to develop a new methodology for measurement of hydrophobic properties of therapeutic agents. This information is important for Quantitative Structure-Activity Relationships (QSAR) analyses. While the QSAR analysis is widely used for common drugs, it is virtually non-existent for various technical reasons for biological agents. The ne...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/00 - 08/31/01

We propose to develop a new methodology for measurement of hydrophobic properties of therapeutic agents. This information is important for Quantitative Structure-Activity Relationships (QSAR) analyses. While the QSAR analysis is widely used for common drugs, it is virtually non-existent for various technical reasons for biological agents. The ne...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/99 - 03/31/00

DESCRIPTION (adapted from applicant's abstract): The innovation described in this proposal is aimed to providing a new method for characterization of lot-to-lot consistency of microheterogeneous recombinant products. The biological effect and potency of a drug is governed by the chemica...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/98 - 03/31/99

DESCRIPTION (adapted from applicant's abstract): The innovation described in this proposal is aimed to providing a new method for characterization of lot-to-lot consistency of microheterogeneous recombinant products. The biological effect and potency of a drug is governed by the chemica...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/25/97 - 09/24/98

DESCRIPTION: (Adapted from the applicant's abstract) The innovation described in this proposal is aimed at providing a new method for detection of carbohydrate-deficient transferrin (CDT) in human blood as a biochemical marker of alcohol abuse. CTD has been extensively shown to be a sensitive and spec...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/97 - 05/31/98

This innovation is aimed at providing a new methodology for quantitative structure-activity relationships (QSAR) analysis of biopharmaceutical agents. Analysis of quantitative structure-activity relationships is fundamentally important for rational drug design. While QSAR analysis is widely used for comm...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/97 - 09/30/97

The innovation described in this proposal is aimed at providing a new method for characterization of lot-to-lot consistency of microheterogeneous recombinant products. The biological effect and potency of a drug is governed by the chemical structure for both traditional drugs and biopharmaceuticals. Sta...

Load More